Elon's Next Market Move Could Send Silver Soaring
Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI.
And now, whispers are growing that his next move could be in silver.
Why? Because silver is the lifeblood of EVs, solar panels, and AI tech.
Without it, Tesla, SpaceX, and Starlink don't grow.
Even back in 2022, Musk hinted at Tesla entering the mining industry. And with new policies clearing the way, the timing couldn't be better.
What happens if Elon enters silver?
- Massive supply chain disruptions – Silver demand is already outpacing supply.
- Prices could surge overnight – Even rumors of Musk in silver could send markets flying.
- A historic opportunity – Investors who act before the headlines could be in for a massive windfall.
Smart money is already watching silver closely.
That's why we put together the 2026 Silver Forecast Guide—your roadmap to silver's biggest growth phase yet.
Click Here to Get your Free Copy Before Silver Moves >>
Because once Musk makes a move, the window to act disappears.
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
Written by Nathan Reiff. Posted: 3/6/2026.
Key Points
- Cash flow generation is a key attribute of stable companies, allowing them flexibility to not only maintain operations but also to grow and to return value to shareholders via dividends or buybacks.
- Gilead Sciences and AbbVie are two large biopharma firms with a compelling history of cash flow generation, helping to facilitate continued R&D and pipeline development, among other things.
- Visa converts about half or more of its revenue to free cash flow, capitalizing on its high-margin business to facilitate growth and dividend payments.
- Special Report: Have $500? Invest in Elon's AI Masterplan
When times get tough for companies, cash flow is an essential element that can determine a firm's viability through a challenging market. Put simply, if a company cannot meet its near-term obligations with cash on hand, it risks failure. Equally important, cash flow enables longer-term planning—everything from expansion and acquisitions to strategic returns of shareholder value.
Though only one of many measures, cash flow may be especially important for investors seeking companies likely to remain steady amid broad market uncertainty in 2026. The three companies below are household names and industry leaders with strong cash-flow histories that support their plans for continued growth.
Strong Free Cash Flow Yield and Commitment to Returning Value to Investors
The table went quiet… [my meeting with Tether Gold] (Ad)
A major force in the crypto world is quietly becoming one of gold's most aggressive buyers — and most investors have no idea it's happening.
A longtime gold analyst says profits from a leading stablecoin operation are being funneled into physical gold at a scale that could materially impact supply and demand. After a recent meeting with insiders, he began outlining what this trend could mean for gold prices and a small group of companies positioned to benefit.
Anchored by top-selling drugs for COVID-19, HIV, certain cancers, and more, Gilead Sciences Inc. (NASDAQ: GILD) is among the largest biopharma firms available to investors. The company offers a compelling balance of free cash flow generation relative to its share price—its free cash flow yield is around 6%.
Importantly, Gilead is committed to returning at least half of its free cash flow to stockholders each year. In 2025, including its dividend distributions, the company returned 63% of its annual free cash flow to shareholders.
Despite its large size and established position, Gilead has continued to grow. In Q4 2025, it beat analyst expectations for both earnings per share and revenue, supported by legacy products and a strong pipeline. In 2026, the company expects at least four major commercial rollouts of new products, helping to maintain a diversified portfolio.
To be sure, Gilead faces significant competition in biopharma, particularly in oncology—an area some investors would like to see expand as a share of total sales. Still, a large majority of Wall Street analysts continue to assign bullish ratings to GILD shares and see roughly 6% additional upside even after the stock's more than 28% gain over the past year.
Massive Dividend Growth Made Possible By Solid Cash Generation Power
Another major biopharma, AbbVie (NYSE: ABBV), posts a free cash flow yield above 5%—strong for a company of its size. While AbbVie provides therapeutics across many medical areas, one of its most compelling attributes for investors is its dividend.
AbbVie has a dividend yield that sits around 2.9% and has more than quadrupled its dividend distributions since going public more than a decade ago.
The company's dividend payout ratio is high—about 293%—which may concern some investors, but it is backed by very strong free cash flow. In 2025, for example, AbbVie generated close to $18 billion in free cash flow while paying out roughly $11.7 billion in total dividends.
AbbVie has continued to build on earnings and revenue, beating Wall Street expectations in Q4 2025 and issuing higher guidance at that time. Growth has been fueled by two of its leading drugs, Skyrizi and Rinvoq, and the company continues to invest heavily in R&D to deepen its pipeline.
Excellent Cash Generation Capacity Amid Consumer Resilience
Credit giant Visa Inc. (NYSE: V) operates a high-margin business model that generates substantial free cash flow, converting half or more of its revenue into free cash flow in many quarters. With solid revenue performance—a 14.6% year-over-year improvement in the latest period, for example—Visa remains a steady cash generator for investors.
Despite macro concerns such as tariffs and inflation, Visa's payments volume and processed transactions continue to rise while consumer spending has proven resilient. This has allowed the company to modestly increase its dividend, which yields about 0.83% and carries a manageable 25.1% payout ratio. Analysts continue to rate Visa shares as a Buy, with roughly 22% upside potential expected going forward.
3 Non-Tech Stocks in TradeSmith's Green Zone for Financial Health
By Jordan Chussler. Article Published: 3/9/2026.
Key Points
- As energy leads the market this year, shares of ExxonMobil are up 26% and its earnings are forecast to rise 21% over the next year.
- Analysts believe Citigroup, which hasn’t missed earnings since Q4 2022, should see share appreciation of 17% over the next 12 months.
- Renewable energy utility company NextEra Energy’s financial health is so robust, its annualized five-year dividend growth rate stands at 10.15%.
- Special Report: Have $500? Invest in Elon's AI Masterplan
When it comes to evaluating stocks, there's no shortage of indicators investors can use to assess fair market value, buy-sell signals and potential price movement.
Those include commonly cited technical indicators such as the Relative Strength Index and Bollinger Bands, along with fundamental metrics like price-to-earnings (P/E) ratios, free cash flow and profitability measures such as return on equity.
The table went quiet… [my meeting with Tether Gold] (Ad)
A major force in the crypto world is quietly becoming one of gold's most aggressive buyers — and most investors have no idea it's happening.
A longtime gold analyst says profits from a leading stablecoin operation are being funneled into physical gold at a scale that could materially impact supply and demand. After a recent meeting with insiders, he began outlining what this trend could mean for gold prices and a small group of companies positioned to benefit.
No matter which indicators investors prefer, they're best used together to build a fuller picture of a company. MarketBeat users can now add another tool to their arsenal: the TradeSmith Health Indicator, which evaluates stocks' health based on price action and volatility, using the proprietary Volatility Quotient to set risk thresholds.
The result is a stoplight-based signal that classifies stocks as Green (financially healthy and in a strong uptrend), Yellow (hold or watch) or Red (financially unhealthy and in a downtrend).
Backtesting shows the indicator performs well: stocks in the Green Zone have recorded more than a 23% average annualized return, while those in the Red Zone have annualized losses of about 2.5%.
Currently, the following three stocks sit squarely in TradeSmith's Green Zone, offering investors a chance to combine the indicator with others to decide whether they fit buy-and-hold portfolios.
ExxonMobil: +6 months in the TradeSmith Green Zone
After years of lagging the market, the energy sector is outperforming the S&P 500, leading all 11 sectors with a year-to-date (YTD) gain of nearly 26% versus the index's YTD loss of 0.4%. This outperformance has been driven in part by oil major ExxonMobil (NYSE: XOM), whose shares are up nearly 23% YTD.
Its forward P/E of roughly 20 is lower than the broad S&P 500's P/E of 28 and is an improvement on its trailing 12-month (TTM) P/E of 22, suggesting earnings are expected to increase and deliver more earnings per dollar invested over the coming year.
That is an attractive value proposition for a company that has beaten analyst expectations for earnings per share (EPS) in six of the last seven quarters, with ExxonMobil's EPS forecast to rise more than 21% next year, from $7.43 to $9.02 per share.
Underpinning ExxonMobil's financial health, the company has averaged stable gross margins of 32.75% over the past 10 years. Over the same period, its average annual debt-to-equity (D/E) ratio was just 0.22—a sign of conservative financing and higher financial stability. In other words, over the past decade ExxonMobil carried only 22 cents of debt for every dollar of shareholder equity.
Citigroup: +8 months in the TradeSmith Green Zone
Global financial services firm Citigroup (NYSE: C) has been in TradeSmith's Green Zone since last July. Its forward P/E of 14.45 improves on its TTM P/E of 15.62, both of which are cheaper multiples than the broad market.
The stock is down more than 8% in 2026 as the financials sector has struggled, posting a nearly 6% YTD loss—the worst among the 11 S&P 500 sectors.
Analysts still see upside over the next year: the average 12-month price target is $127.25, about 17% above today's price. That view is supported by MarketRank™ analysis, which places Citigroup above 97% of companies evaluated by MarketBeat and second out of 62 stocks in the financial services sector.
That favorable assessment reflects solid underlying fundamentals, including a run of earnings beats in 11 of the past 12 quarters (dating back to Q1 2023). Citigroup's earnings are expected to climb 25.5% next year, from $7.53 to $9.45 per share.
Over the past decade, Citigroup has had only one year of net income contraction while averaging annualized profits of $10.8 billion.
NextEra Energy: +5 months in the TradeSmith Green Zone
With a nearly 13% YTD gain, NextEra Energy (NYSE: NEE)—a regulated utility operator and competitive renewable energy generator—has been firmly in TradeSmith's Green Zone since late last year.
The company's forward P/E of 24.51 is an improvement on its TTM P/E of 27.42, and analysts rate the stock a Moderate Buy. NextEra's earnings are expected to grow about 7.6% next year, from $3.68 to $3.96 per share.
One feature that reinforces the TradeSmith health signal is NextEra's dividend, which yields 2.73% today and has delivered an annualized five-year growth rate of 10.15%.
The company has supported that payout with substantial cash-flow growth. Over the past decade, net cash from operating activities rose from $6.36 billion in 2016 to $12.48 billion in 2025—an increase of more than 96%. Over the same period, net income climbed from $2.9 billion to $6.83 billion, up more than 135%.
This email is a paid sponsorship sent on behalf of Priority Gold, a third-party advertiser of InsiderTrades.com and MarketBeat.
If you have questions or concerns about your newsletter, don't hesitate to contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Pl., Sixth Floor, Sioux Falls, South Dakota 57103-7078. United States of America..